06/10/2025
And that's a wrap for . What an amazing conference it has been again this year with so many lovely attendees. With thanks to all the team at BDNG for their hard work and support in organising such a great conference and exhibition - very much appreciated.
We had some fantastic conversations with many of the customers attending about all of our zinc oxide product range, including where and when to use each product. There was a real 'buzz' around our range, especially as we are in the process of making Zipzoc more accessible in the Republic of Ireland, and our Ichthopaste workshops at Derm School were fantastic, with Molly from BDNG.
Janine (UK) & Jonathan (Ireland) are here to support you - please do get in touch if you should require any information.
Thanks again and see you next year!
PRESCRIBING INFORMATION ZIPZOC (zinc impregnated medicated stocking).
Abbreviated prescribing info. Refer to summary of product characteristics before prescribing.
Composition: A sterile rayon stocking impregnated with an ointment containing 20% Zinc Oxide. Each stocking (80cm x 7cm) contains about 41.5g of ointment. Therapeutic indications: Aid to the treatment of chronic leg ulcers and other associated skin conditions. Where chronic venous insufficiency exists, the medicated stocking can be used as a primary contact layer under compression bandaging or hosiery. Method of Administration: Because ZIPZOC is preservative free, it must be changed no less frequently than weekly. For topical application, ZIPZOC should be applied to cover the lower leg from the base of the toes to below the knee. All folds should be smoothed out. To protect clothing, a suitable outer bandage should be worn. If chronic venous insufficiency exists, ZIPZOC may be used as a primary contact layer under compression therapy and may be left in situ for one week, before re-application. Contra-indications: Arterial leg ulcers. Known hypersensitivity to zinc oxide or the excipients in the ointment. Special Warnings and Special Precautions: None known. Interactions: None known. Pregnancy and Lactation: There is no evidence to suggest ZIPZOC should not be used during pregnancy. Undesirable Effects: The skin of leg ulcer patients is easily sensitised to some topical medications. ZIPZOC contains no preservatives thereby reducing the risk of skin reactions. Reported reactions include, rash, erythema, itching and maceration of the wound edge. If the outer bandage is inappropriate or the medicated stocking is not changed with sufficient frequency it can cause the stocking to dry out. Excipients: Liquid Paraffin Ph. Eur. White Soft Paraffin BP. Incompatibilities: None reported. Shelf Life: 3 years. Storage: At or below 30 C. Keep all medicines out of the reach of children. Packaging: Polyethylene aluminium foil laminated pouches, each pouch containing a single medicated stocking. The outer carton will contain either 4 or 10 pouches. Legal Category: P. Market authorization number: PL44616/0002. Date of first authorisation/renewal of the authorisation: 01 October 2006. Date of revision of text: 26 October 2018.
Trademark of Evolan Pharma AB. Date of preparation: October 2018
